Markets

  1. Home
Market Nav

NATCO PHARMA LTD.

  • NSE CodeNATCOPHARMEQ
  • BSE Code524816
  • ISININE987B01026
  • IndustryPharmaceuticals

Company Information

Management

Incorporation Year

19/09/1981

Registered Address

Registered Office : NATCO House, Road # 2, Banjara Hills,
Hyderabad, Telangana - 500034
Tel: 040-23547532
Fax: 040-23548243

Registrar Office

Venture Capital & Corporate Investments Pvt. Ltd.
"Aurum", Door No.4-50/P-II/57/4F & 5F, Plot No.57, 4th & 5th Floo
Hyderabad,500032,Telangana
Tel: 040-23818475
Fax:

Email

investors@natcopharma.co.in

Website

http://www.natcopharma.co.in

Listing

BSE, BSE, MCXSX, NSE

Corporate News

Natco Pharma - Announcement under Regulation 30 (LODR...

17-Oct-2025|5:11PM

Legal update regarding Risdiplam

Natco Pharma - Press Release

17-Oct-2025|5:09PM

Natco Pharma Limited has informed the Exchange regarding a press release da

Natco Pharma has submitted to BSE the Shareholding Pa...

11-Oct-2025|7:04AM

As of September 2025, 49.48% is owned by Promoters and 50.52% by Public.

Natco Pharma - Announcement under Regulation 30 (LODR...

10-Oct-2025|1:09PM

Update on proposed acquisition of Adcock Ingram Holdings Limited

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug89.50253.77
Aarti Drug491.204,483.18
Aarti Pharma831.157,534.15
Abbott India29,770.0063,259.17
Accent Micro271.00650.10
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
Tata Va..125.331.47
Sundara..44.661.34
Tata Sm..43.680.38
Baroda ..15.912.59
Baroda ..11.930.96
More

Board Meetings

DatePurpose
12/08/2025Quarterly Results &..
28/05/2025Audited Results
12/02/2025Quarterly Results &..
12/11/2024Quarterly Results &..
12/08/2024Quarterly Results &..
More